Eton Pharmaceuticals, Inc. Share Price & Technical Analysis
ETON · $32.59 (-6.89%)
Healthcare / Drug Manufacturers - Specialty & Generic
$32.59
-6.89%
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N…
Price chart
Seasonality
May has 3 positive and 1 negative years (last 5 years shown)
33% return in May, 7% avg return in past 3 year May month.
74% return in 2026, 80% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -11% | 12% | 45% | -4% | 33% | – | – | – | – | – | – | – | 74% |
| 25 | 32% | -9% | -17% | 31% | 11% | -24% | 0% | 23% | 28% | -17% | -11% | 6% | 52% |
| 24 | 9% | -6% | -16% | -8% | 0% | -6% | 9% | 24% | 30% | 42% | 59% | -4% | 134% |
| 23 | 21% | 6% | 3% | -5% | 11% | -12% | -20% | 55% | -7% | 0% | -19% | 22% | 55% |
| 22 | -16% | 6% | 16% | -20% | -17% | -19% | 0% | -12% | -5% | 19% | 15% | -7% | -39% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Strong
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$812.86M
P/E ratio
—
52W high
$35.66
52W low
$13.09
Volume
5,24,025
Beta
0.82
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Eton Pharmaceuticals, Inc. share price today?
- Eton Pharmaceuticals, Inc. (ETON) last traded around $32.59 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ETON have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ETON. Download the app for real-time alerts.
- How can I analyze Eton Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.